Luis García-García Selected Research

Pilocarpine (Ocusert)

5/2023	A Single High Dose of Flufenamic Acid in Rats does not Reduce the Damage Associated with the Rat Lithium-Pilocarpine Model of Status Epilepticus but Leads to Deleterious Outcomes.
1/2023	The vasodilator naftidrofuryl attenuates short-term brain glucose hypometabolism in the lithium-pilocarpine rat model of status epilepticus without providing neuroprotection.
1/2018	Metyrapone prevents acute glucose hypermetabolism and short-term brain damage induced by intrahippocampal administration of 4-aminopyridine in rats.
9/2017	Metyrapone prevents brain damage induced by status epilepticus in the rat lithium-pilocarpine model.
5/2016	Serotonin Depletion Does not Modify the Short-Term Brain Hypometabolism and Hippocampal Neurodegeneration Induced by the Lithium-Pilocarpine Model of Status Epilepticus in Rats.
2/2015	Subacute administration of fluoxetine prevents short-term brain hypometabolism and reduces brain damage markers induced by the lithium-pilocarpine model of epilepsy in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luis García-García Research Topics

Disease

7	Status Epilepticus (Complex Partial Status Epilepticus) 05/2023 - 05/2016
6	Epilepsy (Aura) 05/2023 - 02/2015
6	Gliosis 01/2019 - 04/2015
5	Neuroinflammatory Diseases 05/2023 - 01/2012
5	Seizures (Absence Seizure) 04/2023 - 02/2015
3	Nervous System Diseases (Neurological Disorders) 04/2023 - 01/2018
2	Body Weight (Weight, Body) 04/2023 - 03/2015
2	Temporal Lobe Epilepsy 01/2023 - 09/2017
2	Parkinson Disease (Parkinson's Disease) 05/2022 - 11/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2022 - 01/2014
2	Catalepsy 05/2022 - 11/2017
2	Amyloidosis 01/2022 - 11/2016
2	Brain Diseases (Brain Disorder) 01/2019 - 11/2016
2	Alzheimer Disease (Alzheimer's Disease) 11/2016 - 01/2012
1	Vascular Diseases (Vascular Disease) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Insulin Resistance 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2019
1	Central Nervous System Tuberculosis 01/2017
1	AIDS-Related Complex (ARC) 01/2017
1	Tuberculosis (Tuberculoses) 01/2017
1	Ataxia (Dyssynergia) 12/2016
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 12/2016
1	Dystonia (Limb Dystonia) 12/2016
1	Spinocerebellar Degenerations (Marinesco Sjogren Syndrome) 12/2016
1	Muscle Weakness 12/2016
1	Cerebellar Diseases (Cerebellar Syndrome) 12/2016
1	Brain Hypoxia (Cerebral Hypoxia) 08/2015
1	Stroke (Strokes) 08/2015
1	Hypoxia (Hypoxemia) 08/2015
1	Ischemic Stroke 08/2015
1	Tauopathies 01/2014
1	Inflammation (Inflammations) 01/2012
1	Hyperphagia (Overeating) 02/2010

Drug/Important Bio-Agent (IBA)

7	Glucose (Dextrose)FDA LinkGeneric 05/2023 - 11/2016
6	LithiumIBA 05/2023 - 02/2015
6	Pilocarpine (Ocusert)FDA LinkGeneric 05/2023 - 02/2015
6	Glial Fibrillary Acidic ProteinIBA 05/2022 - 04/2015
3	Neuroprotective AgentsIBA 04/2023 - 01/2017
3	CannabinoidsIBA 01/2019 - 01/2012
3	fluoro-jade CIBA 01/2018 - 04/2015
3	Serotonin (5 Hydroxytryptamine)IBA 05/2016 - 02/2015
2	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 05/2022 - 11/2017
2	Metyrapone FDA Link 01/2018 - 09/2017
2	EnzymesIBA 01/2018 - 12/2016
2	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2017 - 02/2010
2	EndocannabinoidsIBA 12/2016 - 11/2016
2	Fluoxetine (Prozac)FDA LinkGeneric 05/2016 - 02/2015
1	Flufenamic AcidIBA 05/2023
1	PhytochemicalsIBA 04/2023
1	CurcuminIBA 04/2023
1	AntioxidantsIBA 04/2023
1	Nafronyl (Naftidrofuryl)IBA 01/2023
1	Vasodilator Agents (Vasodilators)IBA 01/2023
1	Levodopa (L Dopa)FDA LinkGeneric 05/2022
1	Tolcapone (Tasmar)FDA Link 05/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Glycogen Synthase Kinase 3IBA 01/2022
1	Insulin ReceptorIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Technetium Tc 99m Exametazime (Ceretec)FDA Link 12/2021
1	CannabidiolIBA 01/2019
1	5-HT1A Serotonin ReceptorIBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2018
1	ropinirole (Requip)FDA LinkGeneric 11/2017
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 11/2017
1	Proteins (Proteins, Gene)FDA Link 09/2017
1	GlucocorticoidsIBA 09/2017
1	Gatifloxacin (Zymar)FDA Link 01/2017
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2017
1	Antidepressive Agents (Antidepressants)IBA 01/2017
1	CorticosteroneIBA 01/2017
1	Polysorbates (PSML)FDA Link 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Caspase 9IBA 01/2017
1	Glutamic Acid (Glutamate)FDA Link 12/2016
1	anandamide (arachidonylethanolamide)IBA 11/2016
1	fluoromisonidazoleIBA 08/2015
1	pipoxolan (BR 18)IBA 08/2015
1	DAPIIBA 04/2015
1	Appetite Depressants (Anorectics)IBA 03/2015
1	tau Proteins (tau Protein)IBA 01/2014
1	Amyloid (Amyloid Fibrils)IBA 01/2012
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2012
1	LeptinIBA 02/2010

Therapy/Procedure

1	Therapeutics 01/2019
1	Induced Hyperthermia (Thermotherapy) 01/2017